
Opinion|Videos|June 24, 2024
Differential Diagnosis When Considering Hidradenitis Suppurativa in a Patient
Author(s)Iltefat Hamzavi, MD
A dermatologist provides clinical insights on differential diagnosis strategies when considering hidradenitis suppurativa in patients and the challenges associated with diagnosis.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- What is in your differential diagnosis when considering hidradenitis suppurativa (HS) in a patient and how is this disease definitively diagnosed?
- Average delay in HS diagnosis has been found to be around 10 years. What do you think accounts for this and why is it imperative for patients with HS to be diagnosed sooner?
Advertisement
Related to this article

In a single-clinic study, 61.5% of patients with psoriasis screened positive for psoriatic arthritis using a validated questionnaire.

San Francisco experts say payer step edits and weak biologic follow-up slow atopic dermatitis care and point to pharmacy teams and dashboards.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First siRNA Therapy for AChR-Positive Myasthenia Gravis
2
Most Patients With Psoriasis Screened Positive for PsA at One Dermatology Clinic
3
Iron Deficiency in Heart Failure Is a Workflow Problem, Faculty Say
4
Low CRC Incidence Found After Endoscopic Mucosal Resection
5


